Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04244604 · ClinicalTrials.gov registry record · NA
Vascular Effects of Acute Sodium (VEAS) Study
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 71
- Enrollment target
NCT04244604 is a NA study that has completed, run by Indiana University. The registered enrollment target is 71 participants.
The verdict
NCT04244604, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 71 participants
- Enrollment target
Study Summary
This IRB will cover a current clinical trial (NCT04244604) that was started at Auburn University (AU IRB#19-390), the Principal Investigator's prior institution, and is supported by his NIH Career Development Award (NHLBI K01HL147998). About nine out of ten Americans overconsume dietary salt. Compared to other racial groups, Black individuals are more prone to salt-sensitive hypertension and negative cardiovascular conditions associated with high salt intake. However, there is a critical need to determine the reasons behind and mechanisms that contribute to these racial disparities. Both acute (single meal) and chronic high-dietary sodium cause small but important increases in blood sodium concentration that are associated with altered blood pressure regulation and blood vessel dysfunction. However, racial differences in these measures have not been examined. This is important because Black individuals generally exhibit lower circulating concentrations of hormones (e.g., renin, aldosterone, angiotensin 2) that buffer changes in body sodium to regulate blood pressure, and this could make them more vulnerable to the negative effects of a high-sodium meal. Therefore, the purpose of this study is to determine whether there are racial differences in blood pressure regulation and blood flow after a high-sodium meal. The investigators will assess blood pressure regulation, blood vessel stiffness, and the blood vessel's ability to dilate before and after a high-salt meal and a low-salt control meal (both meals are low-salt tomato soup with varied added salt). The investigators will also collect blood and urine to measure sodium and determine biochemical changes that may be contributing to racial differences in cardiovascular function.
Interventions
- OTHER Low Sodium Meal (140 mg sodium chloride)
- OTHER High Sodium Meal (2500 mg sodium chloride)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2021-05-03 |
| Est. Completion | 2025-12-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04244604
The ClinicalTrials.gov registry entry for NCT04244604 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Low Sodium Meal (140 mg sodium chloride) is the first listed.
NCT04244604 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04244604 about?
NCT04244604 is a clinical study titled "Vascular Effects of Acute Sodium (VEAS) Study". This IRB will cover a current clinical trial (NCT04244604) that was started at Auburn University (AU IRB#19-390), the Principal Investigator's prior institution, and is supported by his NIH Career Development Award (NHLBI K01HL147998). About nine out of ten Americans overconsume dietary salt. Compa...
What is the current status of trial NCT04244604?
This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2021-05-03. Estimated completion is 2025-12-15.
What interventions are being tested in trial NCT04244604?
The interventions under investigation include: Low Sodium Meal (140 mg sodium chloride) (OTHER), High Sodium Meal (2500 mg sodium chloride) (OTHER).
Who is sponsoring clinical trial NCT04244604?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.